FDA Inspection 1019048 — Straumann USA LLC

Straumann USA LLC — FEI 1000121052

The FDA completed an inspection of Straumann USA LLC on Jul 21, 2017 in Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 21, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Andover, MA (United States)

Citations

IDCFRDescription
1241121 CFR 1271.260(a)Contamination, mix ups, improper release
1242521 CFR 1271.265(c)(1)Release of HCT/Ps by responsible person
313021 CFR 820.100(a)Lack of or inadequate procedures
337521 CFR 820.198(e)Records of complaint investigation
419321 CFR 806.10(b)Time to report - 10 days
73121 CFR 803.50(a)(1)Report of Death or Serious Injury

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.